| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |